GSK3B and neoplasm: In tumours, GSK-3β has been demonstrated to play a paradoxical role as GSK-3β acts as a tumour promoter or suppressor based on the cell type and phosphorylation status (He et al., 2022; Li et al., 2017; Pecoraro et al., 2021; Zhang et al., 2020).